Another study showed that KRAS mutation subtypes can predict disease recurrence and metastasis after surgical treatment of NSCLC, and patients with NSCLC with KRAS G12V mutation are predisposed to pleura–pericardial metastasis after surgery (Renaud et al., 2016). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.